A R T I C L E S
Kimball et al.
9.1 Hz, 1H), 7.39 (d, J ) 8.4 Hz, 2H), 7.27 (dd, J ) 9.1, 2.1 Hz, 1H),
3.35 (br s, 2H), 3.10 (br s, 2H), 2.43 (s, 3H), 0.73 (t, J ) 7.2 Hz, 6H).
13C NMR (CDCl3) δ 144.78, 144.50, 138.17, 134.68, 129.87, 129.43,
128.24, 121.00, 119.05, 118.16, 52.37, 21.63, 11.87. IR (neat) 3197,
3069, 2925, 1167 cm-1. MS (ESI) m/z (%): 420.1 (100, M+ + H),
319.2 (30, M+ - C4H10N3). Anal. Calcd for C19H22ClN5O2S (419.93):
C, 54.34; H, 5.28; N, 16.68. Found: C, 54.62; H, 5.39; N, 16.57.
6-Chlorocinnoline (3d) from Tosylhydrazone 10. The following
procedure for the formation of the sodium salt of 10 was modified
from the literature.15 To a mixture of NaH (4 mg, 0.17 mmol) in THF
(3 mL) was added via syringe a solution of 10 (64 mg, 0.15 mmol) in
THF (3 mL). After being stirred for 15 min, the solvent was evaporated.
The solid obtained was suspended in ODCB (6 mL) and heated
overnight at 200 °C. After being cooled, the solvent was removed, and
the crude product was purified by preparative TLC (2:1:1 hexanes/
CH2Cl2/EtOAc) to give 3d (R ) Cl, 13 mg, 51%) as a white solid.
Spectral data were identical to those reported previously.6c
d2 (10 equiv) in ODCB (6 mL) and heated to 200 °C for 24 h. The
mixture was cooled and diluted with hexanes. The mixture was vacuum
filtered through silica, washing with 1:1 hexanes/CH2Cl2 to remove
less polar compounds and then eluting the cinnoline products with
1:1 CH2Cl2/EtOAc. Purification by preparative TLC (3:1:1 hexanes/
CH2Cl2/EtOAc) gave 3e/e′/e′′ as given in Table 1. Ratios were
determined by NMR spectroscopy.
6-Diethylaminocinnoline (3g). To a sealable glass pressure tube
was added 1f (R ) F, 106 mg, 0.48 mmol) and ODCB (10 mL). The
tube was sealed and heated to 170 °C with stirring overnight. After
being cooled, the solvent was evaporated, and the crude product was
purified by preparative TLC (2:1:1 hexanes/CH2Cl2/EtOAc) to provide
6-diethylaminocinnoline (3g) (32 mg, 33%) as a yellow oil, in addition
to previously reported cinnoline 3f6c (25 mg, 35%) and isoindazole
2f6c (28 mg, 25%). 3g: 1H NMR (CDCl3) δ 8.90 (d, J ) 5.9 Hz, 1H),
8.24 (d, J ) 9.7 Hz, 1H), 7.48 (d, J ) 6.1 Hz, 1H), 7.37 (dd, J ) 9.7,
2.9 Hz, 1H), 6.52 (d, J ) 2.6 Hz, 1H), 3.51 (q, J ) 7.1 Hz, 4H), 1.26
(t, J ) 7.1 Hz, 6H). 13C NMR (CDCl3) δ 148.57, 146.40, 144.81,
131.10, 129.07, 120.16, 119.76, 99.34, 44.74, 12.56. IR (neat) 3065,
2973, 2932, 2900, 2872, 1683, 1611 cm-1. HRMS calcd for C12H16N3:
202.1344. Found: 202.1342.
Triazene 13. 2-Iodoaniline (219 mg, 1.0 mmol) was dissolved in a
minimal amount of MeCN (3 mL), after which concentrated HCl (0.67
mL, 8.0 mmol) and ice (∼1 g) were added. The suspension was cooled
to -5 °C, and a solution of NaNO2 (173 mg, 2.5 mmol) in water (3
mL) and MeCN (1 mL) was added slowly such that the temperature
remained between -5 and -2 °C. Once the addition was complete,
the solution was stirred at -5 °C for 30 min, after which it was
transferred slowly via cannula to a quench solution of amine 1228 (1.4
g, 10 mmol), K2CO3 (661 mg, 5 mmol), water (30 mL), and MeCN
(10 mL) cooled to 0 °C. Once the transfer was complete, the mixture
was allowed to gradually warm to room temperature overnight. The
mixture was diluted with water and extracted with Et2O. The com-
bined organics were dried (MgSO4), filtered, and concentrated. Puri-
fication by column chromatography (1:1 hexanes/CH2Cl2) provided 13
Triazene 16a. 4-Chloroaniline (750 mg, 5.9 mmol) was combined
with BTEA‚ICl2 (2.5 g, 6.4 mmol) and CaCO3 (650 mg, 6.5 mmol) in
MeOH (5 mL) and CHCl3 (40 mL) and stirred at room temperature
for 24 h. The resulting mixture was filtered, and the solvent was
evaporated. The crude product was redissolved in Et2O and washed
with 5% NaHSO3 solution and then water. The combined organics were
dried (MgSO4), filtered, and concentrated. The resultant solid was used
without additional purification.
The iodinated product (500 mg, 2.0 mmol) was dissolved in MeCN
(5 mL) and reacted with concentrated HCl (1.3 mL, 15.8 mmol), NaNO2
(301 mg, 4.4 mmol), 2,2,6,6-tetramethylpiperidine (3.3 mL, 19.8 mmol),
and K2CO3 (1.32 g, 10 mmol) under conditions analogous to triazene
13. Purification by column chromatography (50:1 hexanes/CH2Cl2)
1
(343 mg, 91%) as a light yellow oil. H NMR (CDCl3) δ 7.95 (dd, J
) 7.8, 1.2 Hz, 1H), 7.53 (d, J ) 7.8 Hz, 1H), 7.48-7.33 (m, 6H), 6.93
(td, J ) 7.8, 1.5 Hz, 1H), 6.67 (d, J ) 15.6 Hz, 1H), 6.40-6.26 (m,
1H), 4.59 (dd, J ) 6.6, 1.5 Hz, 2H), 3.33 (br s, 3H). 13C NMR (CDCl3)
δ 149.81, 138.98, 136.10, 133.58, 128.59, 128.51, 127.83, 126.84,
126.39, 124.25, 117.59, 96.67, 57.96, 34.97. IR (neat) 3058, 3026, 2919,
1449, 1345 cm-1. HRMS calcd for C16H17N3I: 378.0467. Found:
378.0460.
1
provided 16a (260 mg, 32%) as a light yellow oil. H NMR (CDCl3)
δ 7.82 (d, J ) 2.1 Hz, 1H), 7.24 (dd, J ) 8.8, 2.1 Hz, 1H), 7.18 (d, J
) 8.8 Hz, 1H), 1.75-1.70 (m, 6H), 1.56 (s, 12H). 13C NMR (CDCl3)
δ 150.33, 138.11, 130.43, 128.60, 117.60, 96.14, 61.38, 41.53 (br),
28.88 (br), 16.54. IR (neat) 3067, 3015, 2933, 1423, 563 cm-1. MS
(ESI) m/z (%): 406.0 (100, M+ + H), 368.2 (50, M+ - HCl).
Alkyne 17a. Triazene 16a (260 mg, 0.64 mmol) was reacted with
TMSA (0.11 mL, 0.78 mmol), PdCl2(PPh3)2 (21 mg, 0.03 mmol), CuI
(11 mg, 0.06 mmol), and Et3N (20 mL) under conditions analogous to
8. The crude product was concentrated and treated with K2CO3 (790
mg, 6 mmol) under conditions analogous to 11. Purification by column
chromatography (9:1 hexanes/CH2Cl2) provided 17a (150 mg, 77%)
Alkyne 11. Triazene 13 (325 mg, 0.86 mmol) was reacted with
trimethylsilylacetylene (TMSA, 0.18 mL, 1.3 mmol), PdCl2(PPh3)2 (18
mg, 0.026 mmol), CuI (10 mg, 0.052 mmol), and Et3N (20 mL) under
conditions analogous to 8. After concentration, the crude product was
redissolved in MeOH (5 mL) and THF (25 mL), and K2CO3 (570 mg,
4.3 mmol) was added. After being stirred at room temperature for 24
h, the reaction was diluted with Et2O and washed with concentrated
NH4Cl solution. The organic layer was dried (MgSO4), filtered, and
concentrated. Purification by column chromatography (1:1 hexanes/
1
as a white semisolid. H NMR (CDCl3) δ 7.45 (d, J ) 2.3 Hz, 1H),
7.29 (d, J ) 8.5 Hz, 1H), 7.21 (dd, J ) 8.5, 2.3 Hz, 1H), 3.26 (s, 1H),
1.71 (br s, 6H), 1.54 (s, 12H). 13C NMR (CDCl3) δ 152.56, 132.68,
129.43, 129.38, 118.79, 117.19, 81.63, 81.50, 61.15, 41.46 (br), 28.47
(br), 16.65. IR (neat) 3304, 3019, 2939, 2108 cm-1. MS (ESI) m/z
(%): 304.1 (100, M+ + H), 142.1 (50, C9H19N).
1
CH2Cl2) gave 11 (233 mg, 96%) as a yellow oil. H NMR (CDCl3) δ
7.53 (dd, J ) 7.6, 1.5 Hz, 1H), 7.48 (d, J ) 8.2 Hz, 1H), 7.42-7.24
(m, 6H), 7.11 (td, J ) 7.3, 1.2 Hz, 1H), 6.63 (d, J ) 15.8 Hz, 1H),
6.35-6.26 (m, 1H), 4.56 (dd, J ) 6.7, 1.5 Hz, 2H), 3.29 (s, 4H). 13C
NMR (CDCl3) δ 152.47, 136.34, 133.67, 129.38, 128.62, 127.91,
126.48, 125.03, 124.49, 117.22, 117.11, 81.88, 81.04, 58.1 (br), 34.1
(br). IR (neat) 3293, 3060, 3027, 2910, 2582, 2104 cm-1. HRMS calcd
for C18H18N3: 276.1497. Found: 276.1497.
Isoindazole Aldehyde 18 and Dimer 19. To a sealable glass
pressure tube was added triazene 17a (40 mg, 0.13 mmol) and ODCB
(4 mL). The tube was sealed and heated overnight at 200 °C. After
being cooled, the solvent was evaporated, and the crude product was
purified by preparative TLC (6:1:1 hexanes/CH2Cl2/EtOAc) to provide
18 (10 mg, 23%) as a yellow oil and dimer 19 (30 mg, 75%) as a
Thermal Cyclization of 11. Alkyne 11 (70 mg, 0.25 mmol) was
dissolved in ODCB (7 mL) and heated to 200 °C for 24 h. The mixture
was cooled, and the solvent was evaporated. Successive purification
by column chromatography (40-60% CH2Cl2 in hexanes) and prepara-
tive TLC (4:1:1 hexanes/CH2Cl2/EtOAc) gave cinnoline 3 (20 mg, 62%)
1
yellow powder. 18: H NMR (CDCl3) δ 10.34 (s, 1H), 8.23 (d, J )
2.2 Hz, 1H), 7.77 (d, J ) 9.1 Hz, 1H), 7.35 (dd, J ) 9.1, 2.2 Hz, 1H),
1.76-1.72 (m, 6H), 1.59 (s, 6H), 0.74 (s, 6H). 13C NMR (CDCl3) δ
182.54, 143.35, 132.72, 129.06, 128.64, 120.50, 120.30, 119.98, 60.17,
41.10, 31.30, 23.94, 17.71. IR (neat) 3074, 2930, 1728, 1664, 1453,
1
as a light oil along with several other byproducts. H and 13C NMR
analyses and MS spectra of the separated byproducts gave no indication
of structures corresponding to 14 or 15.
Cyclization of 1e in the Presence of Benzhydrol-d1/d2. Alkyne 1e
(50 mg, 0.18 mmol) was combined with benzhydrol-d1 or benzhydrol-
790 cm-1. MS (ESI) m/z (%): 320.1 (100, M+ + H), 282.3 (20, M+
-
HCl), 149.0 (100, M+ - C9H18N3), 142.0 (20, C9H18N). 19: mp 323.5-
325.0 °C. 1H NMR (CDCl3) δ 8.05 (d, J ) 1.5 Hz, 2H), 7.80 (s, 2H),
9
13472 J. AM. CHEM. SOC. VOL. 124, NO. 45, 2002